The company
Vericel Corporation
VCEL · Nasdaq
VCEL stood above a rising 150-day average in 18 of the last 52 weekly readings, including each of the last 17 weeks. It is 3.4% above that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−14 points in four weeks); Health Care: 28% (−9 points in four weeks).
Statistics
- Rotation
- In trend
- Weeks in an uptrend
- 17 in a row
- Industry in uptrend
- 18% -14 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $14.8M
- Officials’ trades on record
- 3
- Institutions holding
- 290 (+35)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 18 of 52 weeks.
Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
3 disclosed lines: House 0, Senate 0, executive 3; 1 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 15 May 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | bought | $15k–$50k | 30 Apr 2026filed 1 Jul 2026 |
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 30 Mar 2026filed 14 May 2026 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Kevin F. McLaughlinDirector | sold | 7,000at $44.53 | 12 Aug 2026filed 14 Aug 2026 |
| Michael HalpinChief Operating Officer | sold | 10,000at $46.84 | 3 Aug 2026filed 5 Aug 2026 |
| Jonathan SiegalPrincipal Accounting Officer | sold | 1,500at $48.90 | 30 Jul 2026filed 31 Jul 2026 |
| Jonathan SiegalPrincipal Accounting Officer | sold | 2,500at $48.90 | 30 Jul 2026filed 31 Jul 2026 |
| Jonathan SiegalPrincipal Accounting Officer | sold | 500at $48.90 | 30 Jul 2026filed 31 Jul 2026 |
| Sean C. FlynnChief Legal Officer | sold | 15,000at $45.64 | 26 Jun 2026filed 30 Jun 2026 |
| Jonathan Mark HopperChief Medical Officer | sold | 5,000at $45.00 | 26 Jun 2026filed 30 Jun 2026 |
| Jonathan Mark HopperChief Medical Officer | sold | 5,000at $45.00 | 26 Jun 2026filed 30 Jun 2026 |
| Joseph Anthony Mara, Jr.Chief Financial Officer | sold | 5,000at $44.75 | 26 Jun 2026filed 30 Jun 2026 |
| Jonathan SiegalPrincipal Accounting Officer | sold | 232at $44.90 | 26 Jun 2026filed 30 Jun 2026 |
| Jonathan SiegalPrincipal Accounting Officer | sold | 2,500at $44.90 | 26 Jun 2026filed 30 Jun 2026 |
| Sean C. FlynnChief Legal Officer | sold | 15,000at $40.21 | 18 Jun 2026filed 22 Jun 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| BlackRock, Inc.added · filed 7 Aug 2026 | 8,092,226$360.0M | +326,882+4.2% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 3,293,975$146.6M | +141,845+4.5% |
| CONGRESS ASSET MANAGEMENT COadded · filed 7 Jul 2026 | 2,916,295$129.7M | +1,409,377+93.5% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 2,255,728$100.4M | +24,972+1.1% |
| Conestoga Capital Advisors, LLCreduced · filed 24 Jul 2026 | 2,083,832$92.7M | -379,480−15.4% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLCadded · filed 12 Aug 2026 | 1,992,855$88.7M | +160,146+8.7% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A.reduced · filed 13 Aug 2026 | 1,639,988$73.0M | -83,584−4.8% |
| Soleus Capital Management, L.P.reduced · filed 11 Aug 2026 | 1,459,152$64.9M | -1,089,927−42.8% |
| GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 2026 | 1,341,244$59.7M | +86,382+6.9% |
| GENEVA CAPITAL MANAGEMENT LLCreduced · filed 6 Aug 2026 | 1,339,123$59.6M | -307,695−18.7% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.